Works matching DE "VIRUS-like particles"
Results: 1197
The Antitumor Efficacy of CpG Oligonucleotides is Improved by Encapsulation in Plant Virus‐Like Particles.
- Published in:
- Advanced Functional Materials, 2020, v. 30, n. 15, p. 1, doi. 10.1002/adfm.201908743
- By:
- Publication type:
- Article
Multi-scale temporal variation of marine femtoplankton and picophytoplankton: the role of size and environment.
- Published in:
- Ocean & Coastal Research, 2022, v. 70, p. 1, doi. 10.1590/2675-2824070.21105cr
- By:
- Publication type:
- Article
Breaking the barrier: membrane fusion triggers innate antiviral immunity.
- Published in:
- Nature Immunology, 2012, v. 13, n. 8, p. 713, doi. 10.1038/ni.2373
- By:
- Publication type:
- Article
猪圆环病毒2 型病毒样颗粒和塞内卡病毒 灭活二联疫苗免疫效力实验.
- Published in:
- Chinese Journal of Preventive Veterinary Medicine / Zhongguo Yufang Shouyi Xuebao, 2022, v. 44, n. 4, p. 411, doi. 10.3969/j.issn.1008-0589.202102011
- By:
- Publication type:
- Article
Molecular properties and diagnostic potential of monoclonal antibodies targeting cytotoxic α-synuclein oligomers.
- Published in:
- NPJ Parkinson's Disease, 2024, v. 10, n. 1, p. 1, doi. 10.1038/s41531-024-00747-6
- By:
- Publication type:
- Article
AS03 adjuvant enhances the magnitude, persistence, and clonal breadth of memory B cell responses to a plant-based COVID-19 vaccine in humans.
- Published in:
- Science Immunology, 2024, v. 9, n. 94, p. 1, doi. 10.1126/sciimmunol.adi8039
- By:
- Publication type:
- Article
Updates on HPV vaccination.
- Published in:
- Obstetrică şi Ginecologie, 2022, v. 70, n. 4, p. 154
- By:
- Publication type:
- Article
Synthesis and Immunological Evaluation of Virus-Like Particle-Milbemycin A<sub>3</sub>/A<sub>4</sub> Conjugates.
- Published in:
- Antibiotics (2079-6382), 2017, v. 6, n. 3, p. 18, doi. 10.3390/antibiotics6030018
- By:
- Publication type:
- Article
Outer Membrane Proteins as Vaccine Targets Against Lawsonia intracellularis in Piglets.
- Published in:
- Vaccines, 2025, v. 13, n. 2, p. 207, doi. 10.3390/vaccines13020207
- By:
- Publication type:
- Article
Revolutionizing Nanovaccines: A New Era of Immunization.
- Published in:
- Vaccines, 2025, v. 13, n. 2, p. 126, doi. 10.3390/vaccines13020126
- By:
- Publication type:
- Article
Outer Membrane Proteins as Vaccine Targets Against Lawsonia intracellularis in Piglets.
- Published in:
- Vaccines, 2025, v. 13, n. 2, p. 207, doi. 10.3390/vaccines13020207
- By:
- Publication type:
- Article
Revolutionizing Nanovaccines: A New Era of Immunization.
- Published in:
- Vaccines, 2025, v. 13, n. 2, p. 126, doi. 10.3390/vaccines13020126
- By:
- Publication type:
- Article
Immunogenicity of HIV-1 Env mRNA and Env-Gag VLP mRNA Vaccines in Mice.
- Published in:
- Vaccines, 2025, v. 13, n. 1, p. 84, doi. 10.3390/vaccines13010084
- By:
- Publication type:
- Article
Persistence of the Immune Response to an Intramuscular Bivalent (GI.1/GII.4) Norovirus Vaccine in Adults.
- Published in:
- Vaccines, 2025, v. 13, n. 1, p. 82, doi. 10.3390/vaccines13010082
- By:
- Publication type:
- Article
Enhanced Immunogenicity of Foot-and-Mouth Disease Virus-like Particles Using a Water-in-Oil-in-Water Adjuvant.
- Published in:
- Vaccines, 2025, v. 13, n. 1, p. 24, doi. 10.3390/vaccines13010024
- By:
- Publication type:
- Article
A Preclinical Immunogenicity Study of the Recombinant Human Papillomavirus Nine-Valent Virus-like Particle Vaccine.
- Published in:
- Vaccines, 2024, v. 12, n. 12, p. 1356, doi. 10.3390/vaccines12121356
- By:
- Publication type:
- Article
Nanoparticles as Delivery Systems for Antigenic Saccharides: From Conjugation Chemistry to Vaccine Design.
- Published in:
- Vaccines, 2024, v. 12, n. 11, p. 1290, doi. 10.3390/vaccines12111290
- By:
- Publication type:
- Article
Engineering Escherichia coli -Derived Nanoparticles for Vaccine Development.
- Published in:
- Vaccines, 2024, v. 12, n. 11, p. 1287, doi. 10.3390/vaccines12111287
- By:
- Publication type:
- Article
Immunogenicity Assessment of a 14-Valent Human Papillomavirus Vaccine Candidate in Mice.
- Published in:
- Vaccines, 2024, v. 12, n. 11, p. 1262, doi. 10.3390/vaccines12111262
- By:
- Publication type:
- Article
Antiretroviral Therapy with Ritonavir-Boosted Atazanavir- and Lopinavir-Containing Regimens Correlates with Diminished HIV-1 Neutralization.
- Published in:
- Vaccines, 2024, v. 12, n. 10, p. 1176, doi. 10.3390/vaccines12101176
- By:
- Publication type:
- Article
Vaccine Potency and Structure of Yeast-Produced Polio Type 2 Stabilized Virus-like Particles.
- Published in:
- Vaccines, 2024, v. 12, n. 9, p. 1077, doi. 10.3390/vaccines12091077
- By:
- Publication type:
- Article
Preclinical Development of a Novel Zika Virus-like Particle Vaccine in Combination with Tetravalent Dengue Virus-like Particle Vaccines.
- Published in:
- Vaccines, 2024, v. 12, n. 9, p. 1053, doi. 10.3390/vaccines12091053
- By:
- Publication type:
- Article
Influenza A Vaccine Candidates Based on Virus-like Particles Formed by Coat Proteins of Single-Stranded RNA Phages Beihai32 and PQ465.
- Published in:
- Vaccines, 2024, v. 12, n. 9, p. 1033, doi. 10.3390/vaccines12091033
- By:
- Publication type:
- Article
Beta Spike-Presenting SARS-CoV-2 Virus-like Particle Vaccine Confers Broad Protection against Other VOCs in Mice.
- Published in:
- Vaccines, 2024, v. 12, n. 9, p. 1007, doi. 10.3390/vaccines12091007
- By:
- Publication type:
- Article
Sequential Immunization with Vaccines Based on SARS-CoV-2 Virus-like Particles Induces Broadly Neutralizing Antibodies.
- Published in:
- Vaccines, 2024, v. 12, n. 8, p. 927, doi. 10.3390/vaccines12080927
- By:
- Publication type:
- Article
Preclinical Evaluation of Novel Sterically Optimized VLP-Based Vaccines against All Four DENV Serotypes.
- Published in:
- Vaccines, 2024, v. 12, n. 8, p. 874, doi. 10.3390/vaccines12080874
- By:
- Publication type:
- Article
Leveraging Immunofocusing and Virus-like Particle Display to Enhance Antibody Responses to the Malaria Blood-Stage Invasion Complex Antigen PfCyRPA.
- Published in:
- Vaccines, 2024, v. 12, n. 8, p. 859, doi. 10.3390/vaccines12080859
- By:
- Publication type:
- Article
Green Routes: Exploring Protein-Based Virus-like Nanoparticle Transport and Immune Activation in Nicotiana benthamiana for Biotechnological Applications.
- Published in:
- Vaccines, 2024, v. 12, n. 8, p. 831, doi. 10.3390/vaccines12080831
- By:
- Publication type:
- Article
Gold Nanoparticle Virus-like Particles Presenting SARS-CoV-2 Spike Protein: Synthesis, Biophysical Properties and Immunogenicity in BALB/c Mice.
- Published in:
- Vaccines, 2024, v. 12, n. 8, p. 829, doi. 10.3390/vaccines12080829
- By:
- Publication type:
- Article
Immunizing Mice with Influenza Virus-like Particles Expressing the Leishmania amazonensis Promastigote Surface Antigen Alleviates Inflammation in Footpad.
- Published in:
- Vaccines, 2024, v. 12, n. 7, p. 793, doi. 10.3390/vaccines12070793
- By:
- Publication type:
- Article
Protection of K18-hACE2 Mice against SARS-CoV-2 Challenge by a Capsid Virus-like Particle-Based Vaccine.
- Published in:
- Vaccines, 2024, v. 12, n. 7, p. 766, doi. 10.3390/vaccines12070766
- By:
- Publication type:
- Article
S2 Peptide-Conjugated SARS-CoV-2 Virus-like Particles Provide Broad Protection against SARS-CoV-2 Variants of Concern.
- Published in:
- Vaccines, 2024, v. 12, n. 6, p. 676, doi. 10.3390/vaccines12060676
- By:
- Publication type:
- Article
Insect Cell-Based Quadrivalent Seasonal Influenza Virus-like Particles Vaccine Elicits Potent Immune Responses in Mice.
- Published in:
- Vaccines, 2024, v. 12, n. 6, p. 667, doi. 10.3390/vaccines12060667
- By:
- Publication type:
- Article
Identifying Key Drivers of Efficient B Cell Responses: On the Role of T Help, Antigen-Organization, and Toll-like Receptor Stimulation for Generating a Neutralizing Anti-Dengue Virus Response.
- Published in:
- Vaccines, 2024, v. 12, n. 6, p. 661, doi. 10.3390/vaccines12060661
- By:
- Publication type:
- Article
A Combined LC-MS and Immunoassay Approach to Characterize Preservative-Induced Destabilization of Human Papillomavirus Virus-like Particles Adsorbed to an Aluminum-Salt Adjuvant.
- Published in:
- Vaccines, 2024, v. 12, n. 6, p. 580, doi. 10.3390/vaccines12060580
- By:
- Publication type:
- Article
Rapid and Scalable Production of Functional SARS-CoV-2 Virus-like Particles (VLPs) by a Stable HEK293 Cell Pool.
- Published in:
- Vaccines, 2024, v. 12, n. 6, p. 561, doi. 10.3390/vaccines12060561
- By:
- Publication type:
- Article
Nucleic Acid Vaccines Encoding Proteins and Virus-like Particles for HIV Prevention.
- Published in:
- Vaccines, 2024, v. 12, n. 3, p. 298, doi. 10.3390/vaccines12030298
- By:
- Publication type:
- Article
Nanoparticles and Antiviral Vaccines.
- Published in:
- Vaccines, 2024, v. 12, n. 1, p. 30, doi. 10.3390/vaccines12010030
- By:
- Publication type:
- Article
Challenges and Opportunities in the Process Development of Chimeric Vaccines.
- Published in:
- Vaccines, 2023, v. 11, n. 12, p. 1828, doi. 10.3390/vaccines11121828
- By:
- Publication type:
- Article
Virus-Like Particles Based on the Novel Goose Parvovirus (NGPV) VP2 Protein Protect Ducks against NGPV Challenge.
- Published in:
- Vaccines, 2023, v. 11, n. 12, p. 1768, doi. 10.3390/vaccines11121768
- By:
- Publication type:
- Article
Gag Virus-like Particles Functionalized with SARS-CoV-2 Variants: Generation, Characterization and Recognition by COVID-19 Convalescent Patients' Sera.
- Published in:
- Vaccines, 2023, v. 11, n. 11, p. 1641, doi. 10.3390/vaccines11111641
- By:
- Publication type:
- Article
An Overview of Recent Developments in the Application of Antigen Displaying Vaccine Platforms: Hints for Future SARS-CoV-2 VLP Vaccines.
- Published in:
- Vaccines, 2023, v. 11, n. 9, p. 1506, doi. 10.3390/vaccines11091506
- By:
- Publication type:
- Article
An Efficient and Scalable Method for the Production of Immunogenic SARS-CoV-2 Virus-like Particles (VLP) from a Mammalian Suspension Cell Line.
- Published in:
- Vaccines, 2023, v. 11, n. 9, p. 1469, doi. 10.3390/vaccines11091469
- By:
- Publication type:
- Article
Selection and Evaluation of Porcine circovirus (PCV) 2d Vaccine Strains to Protect against Currently Prevalent PCV2.
- Published in:
- Vaccines, 2023, v. 11, n. 9, p. 1447, doi. 10.3390/vaccines11091447
- By:
- Publication type:
- Article
Enhancing Anti-SARS-CoV-2 Neutralizing Immunity by Genetic Delivery of Enveloped Virus-like Particles Displaying SARS-CoV-2 Spikes.
- Published in:
- Vaccines, 2023, v. 11, n. 9, p. 1438, doi. 10.3390/vaccines11091438
- By:
- Publication type:
- Article
VP4/VP56/VP35 Virus-like Particles Effectively Protect Grass Carp (Ctenopharyngodon idella) against GCRV-II Infection.
- Published in:
- Vaccines, 2023, v. 11, n. 8, p. 1373, doi. 10.3390/vaccines11081373
- By:
- Publication type:
- Article
Exigency of Plant-Based Vaccine against COVID-19 Emergence as Pandemic Preparedness.
- Published in:
- Vaccines, 2023, v. 11, n. 8, p. 1347, doi. 10.3390/vaccines11081347
- By:
- Publication type:
- Article
Nanoparticle-Based Adjuvants and Delivery Systems for Modern Vaccines.
- Published in:
- Vaccines, 2023, v. 11, n. 7, p. 1172, doi. 10.3390/vaccines11071172
- By:
- Publication type:
- Article
A VLP-Based Vaccine Displaying HBHA and MTP Antigens of Mycobacterium tuberculosis Induces Protective Immune Responses in M. tuberculosis H37Ra Infected Mice.
- Published in:
- Vaccines, 2023, v. 11, n. 5, p. 941, doi. 10.3390/vaccines11050941
- By:
- Publication type:
- Article
Dissolving Microneedles Loaded with Nanoparticle Formulation of Respiratory Syncytial Virus Fusion Protein Virus-like Particles (F-VLPs) Elicits Cellular and Humoral Immune Responses.
- Published in:
- Vaccines, 2023, v. 11, n. 4, p. 866, doi. 10.3390/vaccines11040866
- By:
- Publication type:
- Article